Gaucher disease and pulmonary hypertension in adult libyan female: A case-based literature review

Clicks: 1
ID: 311506
2024
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal

Ranked #199 of 254 articles by views in Yemen Journal of Medicine

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 254 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
Gaucher disease (GD) is a rare autosomal recessive disorder that results from a deficiency in β-glucosidase (GBA) activity due to a GBA gene mutation. GBA hydrolyzes glucocerebrosides into glucose. Deficiency of this enzyme causes accumulation of glucocerebrosides in cells and tissues. Gaucher cell infiltration into the interstitial tissue can be asymptomatic or can cause mild signs and symptoms, such as wheezing and cough. Progressive disease involves Gaucher cells filling the alveolar spaces, causing dyspnea, frequent infections, pneumonia, and exercise intolerance. We report severe pulmonary hypertension in a 41-year Libyan female patient with type 1 GD who was diagnosed at 17 years of age, responding to enzyme replacement therapy.
Reference Key
omran2024gaucher Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Nadya Omran, Amnna Rayani, Elmukhtar Habas
Journal Yemen Journal of Medicine
Year 2024
DOI
10.18231/j.yjom.2024.025
URL
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.